Sign up for our daily briefing
Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.
Stay on top of the latest market trends
Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.
Sports news worthy of your time
Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.
Tech news worthy of your time
Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.
Get the inside stories
Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Want a daily digest of the top Denver news?
Get a daily digest of the most important stories affecting your hometown with Axios Denver
Want a daily digest of the top Des Moines news?
Get a daily digest of the most important stories affecting your hometown with Axios Des Moines
Want a daily digest of the top Twin Cities news?
Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities
Want a daily digest of the top Tampa Bay news?
Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay
Want a daily digest of the top Charlotte news?
Get a daily digest of the most important stories affecting your hometown with Axios Charlotte
Photo: Ina Fassbender/AFP via Getty Images
Pfizer and BioNTech will supply 40 million doses of the coronavirus vaccine to COVAX, the global effort aimed at ensuring that every country has access to COVID-19 vaccines, the drug makers and World Health Organization announced Friday.
Why it matters: WHO chief Tedros Adhanom Ghebreyesus warned earlier this week that the world is "on the brink of a catastrophic moral failure" due to unequal distribution of coronavirus vaccines.
Details: Pfizer will provide the vaccine through the COVAX program at a "not-for-profit price."
- Financial terms of the agreement have not been released, but the WHO said Friday that "rollout will commence with the successful negotiation and execution of supply agreements."
- Delivery of first doses is expected in the first quarter of 2021.
The big picture: COVAX is led by the WHO, Global Alliance for Vaccines and Immunization and the Coalition for Epidemic Preparedness Innovations.
- 92 low- and middle-income countries and economies are eligible to access COVID-19 vaccines through the COVAX Advance Market Commitment (AMC).
What they're saying: "The urgent and equitable roll-out of vaccines is not just a moral imperative, it is also a strategic and economic imperative," Tedros said in a statement Friday.
- "This agreement with Pfizer and BioNTech will enable COVAX to save lives, stabilize health systems and drive the global economic recovery."
Go deeper: Biden to bring U.S. into COVAX vaccine initiative